- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Aclidinium bromide 400 μg/Formoterol Fumarate 12 μg (AB/FF 400/12 μg)
Total 42 results
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Germany, Poland, Israel, Bulgaria, Czechia, Hungary, Spain, Ukraine, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium, Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseRomania, Czech Republic
-
Daewoong Pharmaceutical Co. LTD.Completed
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompletedCOVID-19 | SARS-CoV-2Australia, United States, Philippines
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease - COPDUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Czechia
-
CureVacActive, not recruitingGlioblastomaBelgium, Germany, Netherlands
-
AstraZenecaCompletedEfficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsChronic Obstructive Pulmonary Disease (COPD)Germany
-
Orion Corporation, Orion PharmaCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
AstraZenecaCompletedAsthmaUnited States, South Africa, Hungary, Bulgaria, Czech Republic, Poland
-
NovartisSchering-PloughCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Austria, Belgium, Canada, Denmark, Germany, Italy, Spain, Sweden, United Kingdom, Peru, Brazil, South Africa, Argentina, Russian Federation, Mexico, Puerto Rico, Chile, Norway
-
EMSRecruiting
-
Chiesi Farmaceutici S.p.A.TerminatedChronic Obstructive Pulmonary DiseaseNetherlands
-
AstraZenecaCompletedAsthma (Part 1) | COPD (Part 2)United Kingdom
-
Maastricht University Medical CenterAstraZeneca; Center for Integrated Rehabilitation and Organ Failure HornUnknownChronic Obstructive Airway DiseaseNetherlands
-
AstraZenecaCompleted
-
Ache Laboratorios Farmaceuticos S.A.WithdrawnChronic Obstructive Pulmonary Disease | COPD
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil, United Kingdom, Germany, Philippines, Denmark, Australia, Argentina, India, Belgium
-
University of DundeeAstraZeneca; NHS TaysideCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
University Hospital, BordeauxCompletedChronic Obstructive Pulmonary Disease (COPD)France
-
EMSRecruiting
-
Neutec Ar-Ge San ve Tic A.ŞCompleted
-
Eurofarma Laboratorios S.A.Not yet recruitingChronic Obstructive Pulmonary DiseaseBrazil
-
Merck Sharp & Dohme LLCCompleted
-
Chiesi Farmaceutici S.p.A.SGS S.A.Recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NRF2 Gene Mutation | NFE2L2 Gene MutationUnited States
-
GlaxoSmithKlineCompleted
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseFrance
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsTerminated
-
Medical University of LodzUnknown
-
Chiesi Farmaceutici S.p.A.Completed
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany, Netherlands, Denmark, France, South Africa, Austria, Belgium, Sweden